2015
DOI: 10.5152/tjar.2015.13540
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Posterior Reversible Encephalopathy Syndrome that Occurred in a Patient with Systemic Lupus Erythematosus by Plasmapheresis

Abstract: Posterior reversible encephalopathy syndrome is characterized by visual and mental disturbances, nausea and vomiting and generalized or focal convulsions and often represents itself with parietal and occipital oedema formation. We want to report the treatment of posterior reversible encephalopathy syndrome with plasmapheresis, which developed in a 35-year-old woman with systemic lupus erythematosus diagnosed by renal biopsy 3 years ago. She has been followed up in the intensive care unit three times. However, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…In several studies, the therapeutic role of plasmapheresis in SLE has been mentioned. The use of plasmapheresis has been proposed for the management of lupus-induced diffuse alveolar hemorrhages, retinal vasculitis [ 10 ], posterior reversible encephalopathy syndrome [ 23 ], refractory TTP [ 24 ], lupus cerebritis [ 25 ], and catastrophic APLA [ 26 ]. However, according to our knowledge, for refractory lupus-induced GI vasculitis, no role of plasmapheresis has been mentioned in the literature.…”
Section: Discussionmentioning
confidence: 99%
“…In several studies, the therapeutic role of plasmapheresis in SLE has been mentioned. The use of plasmapheresis has been proposed for the management of lupus-induced diffuse alveolar hemorrhages, retinal vasculitis [ 10 ], posterior reversible encephalopathy syndrome [ 23 ], refractory TTP [ 24 ], lupus cerebritis [ 25 ], and catastrophic APLA [ 26 ]. However, according to our knowledge, for refractory lupus-induced GI vasculitis, no role of plasmapheresis has been mentioned in the literature.…”
Section: Discussionmentioning
confidence: 99%